- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The BCG Tuberculosis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global BCG Tuberculosis Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the BCG Tuberculosis Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While BCG Immunization segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of BCG Tuberculosis Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, and Serum Institute of India, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
BCG Tuberculosis Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BCG Immunization
BCG Treatment
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global BCG Tuberculosis Vaccine market are listed below:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Tuberculosis Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of BCG Tuberculosis Vaccine, with price, sales, revenue and global market share of BCG Tuberculosis Vaccine from 2019 to 2022.
Chapter 3, the BCG Tuberculosis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Tuberculosis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and BCG Tuberculosis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of BCG Tuberculosis Vaccine.
Chapter 13, 14, and 15, to describe BCG Tuberculosis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 BCG Tuberculosis Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global BCG Tuberculosis Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 BCG Immunization
1.2.3 BCG Treatment
1.3 Market Analysis by Application
1.3.1 Overview: Global BCG Tuberculosis Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global BCG Tuberculosis Vaccine Market Size & Forecast
1.4.1 Global BCG Tuberculosis Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global BCG Tuberculosis Vaccine Sales in Volume (2017-2028)
1.4.3 Global BCG Tuberculosis Vaccine Price (2017-2028)
1.5 Global BCG Tuberculosis Vaccine Production Capacity Analysis
1.5.1 Global BCG Tuberculosis Vaccine Total Production Capacity (2017-2028)
1.5.2 Global BCG Tuberculosis Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 BCG Tuberculosis Vaccine Market Drivers
1.6.2 BCG Tuberculosis Vaccine Market Restraints
1.6.3 BCG Tuberculosis Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck BCG Tuberculosis Vaccine Product and Services
2.1.4 Merck BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur BCG Tuberculosis Vaccine Product and Services
2.2.4 Sanofi Pasteur BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Japan BCG Lab
2.3.1 Japan BCG Lab Details
2.3.2 Japan BCG Lab Major Business
2.3.3 Japan BCG Lab BCG Tuberculosis Vaccine Product and Services
2.3.4 Japan BCG Lab BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 China National Biotec
2.4.1 China National Biotec Details
2.4.2 China National Biotec Major Business
2.4.3 China National Biotec BCG Tuberculosis Vaccine Product and Services
2.4.4 China National Biotec BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India BCG Tuberculosis Vaccine Product and Services
2.5.4 Serum Institute of India BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Intervax
2.6.1 Intervax Details
2.6.2 Intervax Major Business
2.6.3 Intervax BCG Tuberculosis Vaccine Product and Services
2.6.4 Intervax BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GSBPL
2.7.1 GSBPL Details
2.7.2 GSBPL Major Business
2.7.3 GSBPL BCG Tuberculosis Vaccine Product and Services
2.7.4 GSBPL BCG Tuberculosis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 BCG Tuberculosis Vaccine Breakdown Data by Manufacturer
3.1 Global BCG Tuberculosis Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global BCG Tuberculosis Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in BCG Tuberculosis Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 BCG Tuberculosis Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 BCG Tuberculosis Vaccine Manufacturer Market Share in 2021
3.5 Global BCG Tuberculosis Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and BCG Tuberculosis Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global BCG Tuberculosis Vaccine Market Size by Region
4.1.1 Global BCG Tuberculosis Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global BCG Tuberculosis Vaccine Revenue by Region (2017-2028)
4.2 North America BCG Tuberculosis Vaccine Revenue (2017-2028)
4.3 Europe BCG Tuberculosis Vaccine Revenue (2017-2028)
4.4 Asia-Pacific BCG Tuberculosis Vaccine Revenue (2017-2028)
4.5 South America BCG Tuberculosis Vaccine Revenue (2017-2028)
4.6 Middle East and Africa BCG Tuberculosis Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global BCG Tuberculosis Vaccine Sales in Volume by Type (2017-2028)
5.2 Global BCG Tuberculosis Vaccine Revenue by Type (2017-2028)
5.3 Global BCG Tuberculosis Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global BCG Tuberculosis Vaccine Sales in Volume by Application (2017-2028)
6.2 Global BCG Tuberculosis Vaccine Revenue by Application (2017-2028)
6.3 Global BCG Tuberculosis Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America BCG Tuberculosis Vaccine Sales by Type (2017-2028)
7.2 North America BCG Tuberculosis Vaccine Sales by Application (2017-2028)
7.3 North America BCG Tuberculosis Vaccine Market Size by Country
7.3.1 North America BCG Tuberculosis Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America BCG Tuberculosis Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe BCG Tuberculosis Vaccine Sales by Type (2017-2028)
8.2 Europe BCG Tuberculosis Vaccine Sales by Application (2017-2028)
8.3 Europe BCG Tuberculosis Vaccine Market Size by Country
8.3.1 Europe BCG Tuberculosis Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe BCG Tuberculosis Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific BCG Tuberculosis Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific BCG Tuberculosis Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific BCG Tuberculosis Vaccine Market Size by Region
9.3.1 Asia-Pacific BCG Tuberculosis Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific BCG Tuberculosis Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America BCG Tuberculosis Vaccine Sales by Type (2017-2028)
10.2 South America BCG Tuberculosis Vaccine Sales by Application (2017-2028)
10.3 South America BCG Tuberculosis Vaccine Market Size by Country
10.3.1 South America BCG Tuberculosis Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America BCG Tuberculosis Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa BCG Tuberculosis Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa BCG Tuberculosis Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa BCG Tuberculosis Vaccine Market Size by Country
11.3.1 Middle East & Africa BCG Tuberculosis Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa BCG Tuberculosis Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of BCG Tuberculosis Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of BCG Tuberculosis Vaccine
12.3 BCG Tuberculosis Vaccine Production Process
12.4 BCG Tuberculosis Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 BCG Tuberculosis Vaccine Typical Distributors
13.3 BCG Tuberculosis Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global BCG Tuberculosis Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global BCG Tuberculosis Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck BCG Tuberculosis Vaccine Product and Services
Table 6. Merck BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Major Business
Table 9. Sanofi Pasteur BCG Tuberculosis Vaccine Product and Services
Table 10. Sanofi Pasteur BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 12. Japan BCG Lab Major Business
Table 13. Japan BCG Lab BCG Tuberculosis Vaccine Product and Services
Table 14. Japan BCG Lab BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 16. China National Biotec Major Business
Table 17. China National Biotec BCG Tuberculosis Vaccine Product and Services
Table 18. China National Biotec BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute of India Major Business
Table 21. Serum Institute of India BCG Tuberculosis Vaccine Product and Services
Table 22. Serum Institute of India BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Intervax Basic Information, Manufacturing Base and Competitors
Table 24. Intervax Major Business
Table 25. Intervax BCG Tuberculosis Vaccine Product and Services
Table 26. Intervax BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GSBPL Basic Information, Manufacturing Base and Competitors
Table 28. GSBPL Major Business
Table 29. GSBPL BCG Tuberculosis Vaccine Product and Services
Table 30. GSBPL BCG Tuberculosis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global BCG Tuberculosis Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global BCG Tuberculosis Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in BCG Tuberculosis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global BCG Tuberculosis Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and BCG Tuberculosis Vaccine Production Site of Key Manufacturer
Table 36. BCG Tuberculosis Vaccine New Entrant and Capacity Expansion Plans
Table 37. BCG Tuberculosis Vaccine Mergers & Acquisitions in the Past Five Years
Table 38. Global BCG Tuberculosis Vaccine Sales by Region (2017-2022) & (K Units)
Table 39. Global BCG Tuberculosis Vaccine Sales by Region (2023-2028) & (K Units)
Table 40. Global BCG Tuberculosis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 41. Global BCG Tuberculosis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 42. Global BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. Global BCG Tuberculosis Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. Global BCG Tuberculosis Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 45. Global BCG Tuberculosis Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 46. Global BCG Tuberculosis Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 47. Global BCG Tuberculosis Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 48. Global BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 49. Global BCG Tuberculosis Vaccine Sales by Application (2023-2028) & (K Units)
Table 50. Global BCG Tuberculosis Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 51. Global BCG Tuberculosis Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 52. Global BCG Tuberculosis Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 53. Global BCG Tuberculosis Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 54. North America BCG Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. North America BCG Tuberculosis Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. North America BCG Tuberculosis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. North America BCG Tuberculosis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. North America BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. North America BCG Tuberculosis Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. North America BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. North America BCG Tuberculosis Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. Europe BCG Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. Europe BCG Tuberculosis Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. Europe BCG Tuberculosis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe BCG Tuberculosis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. Europe BCG Tuberculosis Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. Europe BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. Europe BCG Tuberculosis Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific BCG Tuberculosis Vaccine Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific BCG Tuberculosis Vaccine Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific BCG Tuberculosis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific BCG Tuberculosis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific BCG Tuberculosis Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific BCG Tuberculosis Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. South America BCG Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 79. South America BCG Tuberculosis Vaccine Sales by Country (2023-2028) & (K Units)
Table 80. South America BCG Tuberculosis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 81. South America BCG Tuberculosis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 82. South America BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. South America BCG Tuberculosis Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. South America BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 85. South America BCG Tuberculosis Vaccine Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa BCG Tuberculosis Vaccine Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa BCG Tuberculosis Vaccine Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa BCG Tuberculosis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa BCG Tuberculosis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa BCG Tuberculosis Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa BCG Tuberculosis Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. BCG Tuberculosis Vaccine Raw Material
Table 95. Key Manufacturers of BCG Tuberculosis Vaccine Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. BCG Tuberculosis Vaccine Typical Distributors
Table 99. BCG Tuberculosis Vaccine Typical Customers
List of Figures
Figure 1. BCG Tuberculosis Vaccine Picture
Figure 2. Global BCG Tuberculosis Vaccine Revenue Market Share by Type in 2021
Figure 3. BCG Immunization
Figure 4. BCG Treatment
Figure 5. Global BCG Tuberculosis Vaccine Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global BCG Tuberculosis Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global BCG Tuberculosis Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global BCG Tuberculosis Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global BCG Tuberculosis Vaccine Price (2017-2028) & (US$/Unit)
Figure 13. Global BCG Tuberculosis Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global BCG Tuberculosis Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. BCG Tuberculosis Vaccine Market Drivers
Figure 16. BCG Tuberculosis Vaccine Market Restraints
Figure 17. BCG Tuberculosis Vaccine Market Trends
Figure 18. Global BCG Tuberculosis Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global BCG Tuberculosis Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. BCG Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 BCG Tuberculosis Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 BCG Tuberculosis Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global BCG Tuberculosis Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global BCG Tuberculosis Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America BCG Tuberculosis Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe BCG Tuberculosis Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific BCG Tuberculosis Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America BCG Tuberculosis Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa BCG Tuberculosis Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global BCG Tuberculosis Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global BCG Tuberculosis Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America BCG Tuberculosis Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America BCG Tuberculosis Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe BCG Tuberculosis Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe BCG Tuberculosis Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific BCG Tuberculosis Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific BCG Tuberculosis Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific BCG Tuberculosis Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America BCG Tuberculosis Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America BCG Tuberculosis Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa BCG Tuberculosis Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa BCG Tuberculosis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of BCG Tuberculosis Vaccine in 2021
Figure 77. Manufacturing Process Analysis of BCG Tuberculosis Vaccine
Figure 78. BCG Tuberculosis Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
